Prediction of disease recurrence in patients after complete PanNET G2 resection

#3745

Introduction: The number of pancreatic neuroendocrine tumors (PanNETs) detected has been increasing over the past decade. Surgical resection is the only potentially curative treatment for PanNETs, but the risk factors for recurrence are not fully understood, which is of clinical value especially for G2 PanNETs due to their high heterogeneity.

Aim(s): Analysis of potential clinical risk factors for PanNET G2 recurrence in patients treated with elective radical surgery.

Materials and methods: 77 patients diagnosed with PanNET G2, referred for surgery with intention of radical cure in 2006-2020.

Conference:

Presenting Author:

Authors: Opalinska M, Olearska H, Sowa-Staszczak A, Morawiec-Sławek K, Kurzyńska A,

Keywords: PanNET G2, recurrence risk, NET G2, surgery, PanNET,

To read the full abstract, please log into your ENETS Member account.